Axa’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,400
Closed -$509K 1240
2022
Q3
$509K Buy
+28,400
New +$373K ﹤0.01% 963
2021
Q2
Sell
-13,500
Closed -$83K 1319
2021
Q1
$83K Buy
+13,500
New +$81.9K ﹤0.01% 1193
2020
Q3
Sell
-33,500
Closed -$171K 1373
2020
Q2
$171K Sell
33,500
-37,141
-53% -$155K ﹤0.01% 1185
2020
Q1
$243K Buy
70,641
+17,900
+34% +$105K ﹤0.01% 1082
2019
Q4
$453K Buy
+52,741
New +$188K ﹤0.01% 1014
2016
Q4
Sell
-164,637
Closed -$7.59M 1302
2016
Q3
$7.59M Sell
164,637
-9,174
-5% -$517K 0.03% 480
2016
Q2
$8.87M Sell
173,811
-7,109
-4% -$353K 0.04% 427
2016
Q1
$7.65M Sell
180,920
-2,922
-2% -$149K 0.03% 451
2015
Q4
$14.4M Sell
183,842
-33,311
-15% -$1.93M 0.06% 293
2015
Q3
$8.8M Buy
217,153
+41,635
+24% +$2.21M 0.04% 410
2015
Q2
$9.14M Buy
175,518
+79,754
+83% +$3.97M 0.04% 446
2015
Q1
$4.46M Buy
95,764
+6,763
+8% +$351K 0.02% 629
2014
Q4
$3.99M Buy
89,001
+5,695
+7% +$239K 0.02% 619
2014
Q3
$3.24M Buy
+83,306
New +$3.27M 0.01% 624

Other funds holding ISEE

Axa's ISEE Position: Q4 2022 in Review

Axa sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 28,400 shares — an estimated $509K sold.

Axa first reported a position in ISEE in Q3 2014 and held it in 14 quarters. The position peaked at $14.4M in Q4 2015. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Axa reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Axa sold 28,400 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $509K.
  • Axa first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 14 quarters.
  • Axa's IVERIC bio, Inc. Common Stock position peaked at $14.4M in Q4 2015.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.